IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 241 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $492,674 | -33.0% | 108,280 | +3.6% | 0.04% | -39.7% |
| Q2 2023 | $735,497 | -33.9% | 104,474 | -42.6% | 0.06% | -40.0% |
| Q1 2023 | $1,112,686 | -4.4% | 182,109 | 0.0% | 0.10% | +18.0% |
| Q4 2022 | $1,163,677 | -30.6% | 182,109 | +4.1% | 0.09% | -29.4% |
| Q3 2022 | $1,677,000 | +1.3% | 175,000 | +16.7% | 0.13% | +10.5% |
| Q2 2022 | $1,656,000 | -0.5% | 150,000 | +50.0% | 0.11% | 0.0% |
| Q1 2022 | $1,665,000 | – | 100,000 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |